Neurology Care Reimagined: In-Office Dispensing Comes to Las Vegas

HOUSTON, TX – April 23, 2026 – Patients with complex neurological conditions in Southern Nevada will now be able to receive their specialty medications directly from their doctor's office, a significant shift from the traditional pharmacy model. Las Vegas Neurology Center, the largest neurology practice in the state, has expanded its partnership with healthcare technology firm Elevate Health Technologies to implement a Physician Medication Dispensing program.

This initiative, also known as Medically Integrated Dispensing (MID), builds upon the center's existing in-office infusion services. By integrating medication dispensing directly at the point of care, the partnership aims to dismantle common barriers patients face, such as insurance complexities, medication delivery delays, and fragmented communication between providers and external pharmacies. The move signals a growing trend toward more consolidated, patient-centric healthcare delivery for managing chronic diseases.

A Prescription for Convenience: The Patient Experience Transformed

For patients managing chronic neurological diseases like multiple sclerosis, Alzheimer's, or movement disorders, the journey to obtain specialty medications is often fraught with logistical hurdles. The process can involve navigating complex prior authorizations, coordinating with mail-order specialty pharmacies, and enduring anxious waits for critical medication deliveries. These obstacles contribute to a well-documented problem in healthcare: medication non-adherence. Industry data reveals a staggering number of prescriptions are abandoned at the pharmacy each year, often due to cost, complexity, or delays in initiation—a delay that can stretch for weeks with some specialty drugs.

The MID model implemented at Las Vegas Neurology Center directly confronts these challenges. By enabling patients to pick up their prescriptions at the conclusion of their appointment, the system eliminates an extra trip and the uncertainty of mail-order services. This immediate access is more than just a convenience; it is a critical component of effective treatment.

Furthermore, integrating dispensing into the physician's office enhances patient education. Neurologists and their clinical staff can provide on-the-spot counseling about a medication's use, potential side effects, and its role in the overall treatment plan. This direct line of communication with a trusted care team can significantly improve a patient's understanding and comfort with their regimen. Research has shown that in-office dispensing can dramatically boost medication adherence rates, with some studies indicating an increase to over 90%, a substantial improvement over the national average. This enhanced continuity ensures the entire care team has real-time visibility into whether a patient has started their therapy, allowing for quicker interventions and adjustments.

The Strategic Shift: Integrating Care for Better Practice Health

While the benefits for patients are clear, the adoption of medically integrated dispensing also represents a strategic business decision for healthcare providers like the Las Vegas Neurology Center. In an increasingly competitive landscape, practices are seeking ways to improve operational efficiency, strengthen patient retention, and create new revenue streams to counter downward pressure on reimbursements.

Technology platforms like Elevate Health Technologies' OnePulse Connect are the engine behind this transformation. These integrated systems unify previously siloed functions—such as buy-and-bill management, inventory and procurement, in-office infusions, and now, medication dispensing—into a single, streamlined workflow. This reduces the administrative burden on staff, who would otherwise spend countless hours coordinating with external pharmacies and navigating insurance paperwork. By automating benefits investigation and prior authorization within the same system, practices can free up valuable time to focus on direct patient care.

From a financial perspective, MID allows a practice to capture revenue from dispensing medications that would otherwise go to an external specialty pharmacy. This can provide a crucial economic buffer, supporting the practice's long-term viability. Moreover, by offering a more seamless and convenient patient experience, practices can significantly boost patient satisfaction and loyalty. When patients feel their care is coordinated and their time is valued, they are more likely to remain with the practice, a key factor in sustainable growth.

Navigating a New Frontier in Specialty Drug Delivery

The partnership in Las Vegas is a microcosm of a larger disruption occurring across the U.S. healthcare system. The traditional model, where prescribing and dispensing are strictly separated, is being challenged by integrated systems that promise better outcomes and efficiency. The rise of complex oral specialty drugs has accelerated this trend, as their management often requires a higher degree of clinical oversight than what a traditional pharmacy can provide.

Elevate Health Technologies is one of several companies pioneering this space. Competitors ranging from large distributors like Cardinal Health to focused tech firms like House Rx are also offering solutions to help specialty practices in oncology, rheumatology, and urology set up their own in-office dispensaries. This growing market underscores a fundamental belief that care is most effective when it is coordinated and managed directly by the prescribing physician's team.

These technology platforms do more than just facilitate dispensing; they offer sophisticated tools for inventory and procurement management. This helps practices avoid overstocking or understocking expensive specialty drugs, manage expiration dates, and ensure compliance with tracking regulations, ultimately reducing waste and optimizing financial performance.

The Regulatory Maze and the Path Forward

Despite its clear benefits, the path to implementing a medically integrated dispensary is not without its obstacles. The regulatory landscape for physician dispensing is a complex patchwork of state and federal laws. In Nevada, for instance, physicians, physician assistants, and nurse practitioners are permitted to dispense medications but must first obtain a specific permit from the state's Board of Pharmacy.

These regulations impose strict requirements for everything from the physical storage and security of medications—especially for controlled substances—to meticulous record-keeping and labeling. Practices must invest in the infrastructure and training necessary to ensure full compliance, as failure to do so can result in significant penalties.

Beyond the regulatory hurdles, practices face financial challenges from Pharmacy Benefit Managers (PBMs). These powerful intermediaries in the drug supply chain often offer low reimbursement rates that can fail to cover the cost of the specialty drugs and the associated clinical services. Navigating contracts with PBMs and Pharmacy Services Administrative Organizations (PSAOs) is a critical and often difficult step for practices looking to make their MID program financially sustainable. The model also raises historical concerns about potential conflicts of interest, though proponents argue that the benefits of improved adherence and coordinated care outweigh these risks when proper oversight is in place. The success of this evolving care model will ultimately depend on its ability to prove its value not just to patients and providers, but to the payers and regulators who shape the healthcare ecosystem.